Other ILD-related CVD-co-morbidities


No definition available.

Endpoint definition

FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None


diagram downward connector

Check conditions None


diagram downward connector

Filter registries None


diagram downward connector

Check pre-conditions, main-only, mode, ICD version None


diagram downward connector

Check minimum number of events None


diagram downward connector
diagram bullet diagram downward connector

Include endpoints


diagram downward connector

Extra metadata

First used in FinnGen datafreeze DF2

Similar endpoints

List of similar endpoints to Other ILD-related CVD-co-morbidities based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Broader endpoints:

Venn diagram with a set fully inside an highlighted set Narrower endpoints:

Show all endpoint correlations

Summary Statistics

Key figures

All Female Male
Number of individuals 9179 4474 4705
Unadjusted prevalence (%) 2.58 2.25 2.99
Mean age at first event (years) 63.25 61.18 65.22


Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.10 6.37 [5.37, 7.55] 1.6e-100 2659
15 years 0.01 1.62 [1.38, 1.91] 5.7e-9 501
5 years 0.01 5.45 [4.71, 6.29] <1e-100 702
1 year 0.01 42.53 [37.36, 48.42] <1e-100 1334

Age distribution of first events

Year distribution of first events

Cumulative Incidence


Index endpoint: OTHER_ILD_CVD_COMORB – Other ILD-related CVD-co-morbidities
GWS hits:

Survival analyses between endpoints


before Other ILD-related CVD-co-morbidities
after Other ILD-related CVD-co-morbidities

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Other ILD-related CVD-co-morbidities